InsidersTradesSigma
Browse the complete record of transactions filed by Giffin Brett A., Directeur Commercial. Insider active across 1 companies, notably T2 Biosystems, Inc.. Aggregated, 1 filings have been recorded. Total volume traded: €5k. The latest transaction was filed on 8 April 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Giffin Brett A. is the Chief Commercial Officer at T2 Biosystems, Inc., a company specializing in medical diagnostics. He is responsible for commercial strategy and business development, contributing to the company's growth.